Immunotherapy-Related Cardiotoxicity Re-Emergence in Non-Small Cell Lung Cancer – A Case Report

PD-1/PD-L1 inhibitors activate immunological response and have become one of the main modalities of cancer treatment. However, they may result in the immune-related adverse events (irAEs). Immune-related cardiotoxicity is relatively rare but may become fatal. We will present a case of a male patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yuanxiang, Hu, Yang, Yang, Bin, Jin, Caibao, Ren, Hui, Wu, Jingyi, Wang, Zhijun, Wei, Youying, Yang, Ling, Hu, Yanping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627268/
https://www.ncbi.nlm.nih.gov/pubmed/34848973
http://dx.doi.org/10.2147/OTT.S333242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627268/
https://www.ncbi.nlm.nih.gov/pubmed/34848973
http://dx.doi.org/10.2147/OTT.S333242

Ejemplares similares